Completed PHASE3 INTERVENTIONAL 4-arm NCT00840242

Smoking Reduction or Cessation With Nicotine Replacement Therapy

Smoking Reduction or Cessation With Nicotine Replacement Therapy. A Placebo Controlled Double Blind Trial With Nicotine Gum or Inhaler.

Sponsor: McNeil AB

Conditions Smoking Cessation

Interventions Nicotine gum Nicotine inhaler Placebo gum Placebo inhaler

Updated 6 times since 2017 Last updated: Apr 24, 2012 Started: Feb 28, 1999 Primary completion: May 31, 2000 Completion: May 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00840242, this PHASE3 trial focuses on Smoking Cessation and remains completed. Sponsored by McNeil AB, it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

McNeil AB

Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kutná Hora, Czechia
• Prague, Czechia